The E2 ubiquitin-conjugating enzyme HIP2 is a crucial regulator of quality control against mutant SOD1 proteotoxicity.
暂无分享,去创建一个
[1] M. Selbach,et al. The UBA domain of conjugating enzyme Ubc1/Ube2K facilitates assembly of K48/K63‐branched ubiquitin chains , 2021, The EMBO journal.
[2] Seongman Kang,et al. ALS-Related Mutant SOD1 Aggregates Interfere with Mitophagy by Sequestering the Autophagy Receptor Optineurin , 2020, International journal of molecular sciences.
[3] A. Gitler,et al. ALS Genetics: Gains, Losses, and Implications for Future Therapies , 2020, Neuron.
[4] G. Shaw,et al. Recruitment of Ubiquitin within an E2 Chain Elongation Complex. , 2020, Biophysical journal.
[5] I. Dikic,et al. Cellular quality control by the ubiquitin-proteasome system and autophagy , 2019, Science.
[6] A. Kidera,et al. Crystal structure of the Ube2K/E2-25K and K48-linked di-ubiquitin complex provides structural insight into the mechanism of K48-specific ubiquitin chain synthesis. , 2018, Biochemical and biophysical research communications.
[7] Shengdi Chen,et al. Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson’s disease models , 2018, Cell Death & Disease.
[8] Seongman Kang,et al. Hip2 ubiquitin-conjugating enzyme has a role in UV-induced G1/S arrest and re-entry , 2018, Genes & Genomics.
[9] In Young Lee,et al. Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment , 2017, Human molecular genetics.
[10] Seongman Kang,et al. Ataxin-1 regulates epithelial–mesenchymal transition of cervical cancer cells , 2017, Oncotarget.
[11] Robert H. Brown,et al. Amyotrophic Lateral Sclerosis. , 2017, The New England journal of medicine.
[12] Robert H. Brown,et al. Decoding ALS: from genes to mechanism , 2016, Nature.
[13] S. Saxena,et al. Proteostasis impairment in ALS , 2016, Brain Research.
[14] C. Day,et al. The molecular basis of lysine 48 ubiquitin chain synthesis by Ube2K , 2015, Scientific Reports.
[15] Jimin Pei,et al. LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins , 2015, Bioinform..
[16] A. Nesvizhskii,et al. Analysis of Protein Stability by the Cycloheximide Chase Assay. , 2015, Bio-protocol.
[17] Jian Li,et al. Broncho-Vaxom Attenuates Allergic Airway Inflammation by Restoring GSK3β-Related T Regulatory Cell Insufficiency , 2014, PloS one.
[18] Song Hwa Jung,et al. Hip2 ubiquitin-conjugating enzyme overcomes radiation-induced G2/M arrest. , 2013, Biochimica et biophysica acta.
[19] Seongman Kang,et al. Characterization and Hsp104-induced artificial clearance of familial ALS-related SOD1 aggregates. , 2013, Biochemical and biophysical research communications.
[20] M. Swash,et al. Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.
[21] F. Leeuwen,et al. The ubiquitin proteasome system in neurodegenerative diseases: Culprit, accomplice or victim? , 2012, Progress in Neurobiology.
[22] Matthew C. Kiernan,et al. Clinical diagnosis and management of amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.
[23] N. Maragakis,et al. Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo , 2011, Proceedings of the National Academy of Sciences.
[24] D. Morgan,et al. Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin. , 2010, Molecular cell.
[25] Robert H. Brown,et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2 , 2010, Human molecular genetics.
[26] J. Julien,et al. Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury , 2010, Glia.
[27] Guanghui Wang,et al. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. , 2009, Human molecular genetics.
[28] Seongman Kang,et al. Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis , 2009, Experimental & Molecular Medicine.
[29] I. Bertini,et al. Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants , 2009, Proceedings of the National Academy of Sciences.
[30] J. Rothstein,et al. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis , 2009, Annals of neurology.
[31] Y. Kong,et al. E2-25K/Hip-2 regulates caspase-12 in ER stress–mediated Aβ neurotoxicity , 2008, The Journal of cell biology.
[32] Takanori Yokota,et al. Als-linked Mutant Sod1 Induces Er Stress-and Ask1-dependent Motor Neuron Death by Targeting Derlin-1 -induced Cell Death Remains Controversial. Here We Show That Sod1 Mut Specifically Interacted with Derlin-1, a Component of Endoplasmic Reticulum (er)-associated Degradation (erad) Machinery and Trig , 2022 .
[33] C. Behl,et al. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation. , 2008, Human molecular genetics.
[34] Richard I. Morimoto,et al. Adapting Proteostasis for Disease Intervention , 2008, Science.
[35] Y. Shyu,et al. Visualization of AP-1–NF-κB ternary complexes in living cells by using a BiFC-based FRET , 2008, Proceedings of the National Academy of Sciences.
[36] I. Bertini,et al. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS , 2007, Proceedings of the National Academy of Sciences.
[37] Sebastian A. Wagner,et al. E3-independent monoubiquitination of ubiquitin-binding proteins. , 2007, Molecular cell.
[38] R. Roos,et al. Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases , 2007, Molecular and Cellular Neuroscience.
[39] E. Kabashi,et al. Failure of protein quality control in amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.
[40] D. Rubinsztein,et al. The roles of intracellular protein-degradation pathways in neurodegeneration , 2006, Nature.
[41] T. Rapoport,et al. E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Ross,et al. What is the role of protein aggregation in neurodegeneration? , 2005, Nature Reviews Molecular Cell Biology.
[43] J. Valentine,et al. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. , 2005, Annual review of biochemistry.
[44] J. Agar,et al. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.
[45] Søren Brunak,et al. Analysis and prediction of leucine-rich nuclear export signals. , 2004, Protein engineering, design & selection : PEDS.
[46] Y. Itoyama,et al. NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1* , 2004, Journal of Biological Chemistry.
[47] S. Kim,et al. Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity , 2003 .
[48] R. Takahashi,et al. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.
[49] Naoyuki Taniguchi,et al. Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity* , 2002, The Journal of Biological Chemistry.
[50] C. Pickart,et al. Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element. , 1997, Biochemistry.
[51] I. Fridovich,et al. Superoxide radical and superoxide dismutases. , 1995, Annual review of biochemistry.
[52] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[53] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[54] C. Pickart,et al. A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multi-ubiquitin chain synthesis via lysine 48 of ubiquitin. , 1990, The Journal of biological chemistry.